Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lukas Sturm

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Hepatology Communications|April 16, 2021
Prognostic Value of the CLIF-C AD Score in Patients With Implantation of Transjugular Intrahepatic Portosystemic ShuntLukas Sturm, Michael Praktiknjo, Dominik Bettinger, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 9, 2024
The Freiburg Index of Post-TIPS Survival accurately predicts mortality in patients with acute decompensation of cirrhosisEric Kalo, Lukas Sturm, Michael Schultheiss, et al.
Alimentary Pharmacology & Therapeutics|February 18, 2026
Altered Pathogen Spectrum of Spontaneous Bacterial Peritonitis in Patients Treated With Proton Pump InhibitorsPhilip Kitchen, Sarah L Schütte, Tammo L Tergast, et al.
Frontiers in Oncology|April 5, 2021
Efficacy of Stereotactic Body Radiotherapy in Patients With Hepatocellular Carcinoma Not Suitable for Transarterial Chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study)Thomas B Brunner, Dominik Bettinger, Michael Schultheiss, et al.
Hepatology Communications|February 24, 2025
MCAM is a prognostic biomarker in patients with liver cirrhosis and HCCEva Stockinger, Hendrik Luxenburger, Dominik Bettinger, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 8, 2025
Right Ventricular Contractility Predicts Clearance of Ascites After Transjugular Intrahepatic Portosystemic ShuntLukas A Heger, Johannes Chang, Charlotte Rohrer, et al.
Cancers|July 14, 2023
Impact of COVID-19 on 1-Year Survival Outcomes in Hepatocellular Carcinoma: A Multicenter Cohort StudyShuell De Souza, Jeffrey Kahol de Jong, Ylenia Perone, et al.
Hepatology International|April 5, 2022
Aspirin improves transplant-free survival after TIPS implantation in patients with refractory ascites: a retrospective multicentre cohort studyLeon Louis Seifert, Philipp Schindler, Lukas Sturm, et al.
Cardiovascular and Interventional Radiology|February 28, 2023
Textbook Outcome After Trans-arterial Chemoembolization for Hepatocellular CarcinomaCristina Mosconi, Joanne O'Rourke, Roman Kloeckner, et al.
Alimentary Pharmacology & Therapeutics|June 8, 2020
A prospective, multicentre study in acute non-cirrhotic, non-malignant portal vein thrombosis: comparison of medical and interventional treatmentMartin Rössle, Dominik Bettinger, Jonel Trebicka, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Hepatology Communications|April 16, 2021
Prognostic Value of the CLIF-C AD Score in Patients With Implantation of Transjugular Intrahepatic Portosystemic ShuntLukas Sturm, Michael Praktiknjo, Dominik Bettinger, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 9, 2024
The Freiburg Index of Post-TIPS Survival accurately predicts mortality in patients with acute decompensation of cirrhosisEric Kalo, Lukas Sturm, Michael Schultheiss, et al.
Alimentary Pharmacology & Therapeutics|February 18, 2026
Altered Pathogen Spectrum of Spontaneous Bacterial Peritonitis in Patients Treated With Proton Pump InhibitorsPhilip Kitchen, Sarah L Schütte, Tammo L Tergast, et al.
Frontiers in Oncology|April 5, 2021
Efficacy of Stereotactic Body Radiotherapy in Patients With Hepatocellular Carcinoma Not Suitable for Transarterial Chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study)Thomas B Brunner, Dominik Bettinger, Michael Schultheiss, et al.
Hepatology Communications|February 24, 2025
MCAM is a prognostic biomarker in patients with liver cirrhosis and HCCEva Stockinger, Hendrik Luxenburger, Dominik Bettinger, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 8, 2025
Right Ventricular Contractility Predicts Clearance of Ascites After Transjugular Intrahepatic Portosystemic ShuntLukas A Heger, Johannes Chang, Charlotte Rohrer, et al.
Cancers|July 14, 2023
Impact of COVID-19 on 1-Year Survival Outcomes in Hepatocellular Carcinoma: A Multicenter Cohort StudyShuell De Souza, Jeffrey Kahol de Jong, Ylenia Perone, et al.
Hepatology International|April 5, 2022
Aspirin improves transplant-free survival after TIPS implantation in patients with refractory ascites: a retrospective multicentre cohort studyLeon Louis Seifert, Philipp Schindler, Lukas Sturm, et al.
Cardiovascular and Interventional Radiology|February 28, 2023
Textbook Outcome After Trans-arterial Chemoembolization for Hepatocellular CarcinomaCristina Mosconi, Joanne O'Rourke, Roman Kloeckner, et al.
Alimentary Pharmacology & Therapeutics|June 8, 2020
A prospective, multicentre study in acute non-cirrhotic, non-malignant portal vein thrombosis: comparison of medical and interventional treatmentMartin Rössle, Dominik Bettinger, Jonel Trebicka, et al.
Pageof 5